Metraipolis › archive › dc_1f48dc4acade

On-treatment modified Glasgow Prognostic Score (mGPS) in hepatocellular carcinoma treated with atezolizumab and bevacizumab provides prognostic information — Europe PMC PMID:41142780

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41142780
DOI
10.3389/fimmu.2025.1599143
License (as archived)
solo-consultazione
Archived
2026-11-09T11:08:39.802Z
SHA-256 of the archived text
c9d5569254587dfa38d74a97abb453dfad2ebea15412e7a4ae879c9c838fe25e
Stable URL of this page
https://metraipolis.com/documento/dc_1f48dc4acade

How to cite

On-treatment modified Glasgow Prognostic Score (mGPS) in hepatocellular carcinoma treated with atezolizumab and bevacizumab provides prognostic information — Europe PMC PMID:41142780 — Europe PMC (en), https://europepmc.org/article/MED/41142780 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1f48dc4acade (Metraipolis archive dc_1f48dc4acade, sha256 c9d5569254587dfa38d74a97abb453dfad2ebea15412e7a4ae879c9c838fe25e)
BibTeX
@misc{dc1f48dc4acade,
  title = {On-treatment modified Glasgow Prognostic Score (mGPS) in hepatocellular carcinoma treated with atezolizumab and bevacizumab provides prognostic information — Europe PMC PMID:41142780},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41142780},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1f48dc4acade; sha256 c9d5569254587dfa38d74a97abb453dfad2ebea15412e7a4ae879c9c838fe25e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41142780. Agents can read the archived copy with the MCP tool read_document.